Annual Net Income
-$50.73 M
+$2.28 M+4.30%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual net profit is -$50.73 million, with the most recent change of +$2.28 million (+4.30%) on December 31, 2023.
- During the last 3 years, CUE annual net income has fallen by -$5.95 million (-13.28%).
- CUE annual net income is now -2530.42% below its all-time high of -$1.93 million, reached on December 31, 2015.
Performance
CUE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$8.66 M
+$1.51 M+14.86%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly net profit is -$8.66 million, with the most recent change of +$1.51 million (+14.86%) on September 30, 2024.
- Over the past year, CUE quarterly net income has increased by +$1.51 million (+14.86%).
- CUE quarterly net income is now -327.84% below its all-time high of -$2.02 million, reached on September 30, 2016.
Performance
CUE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$44.61 M
+$2.35 M+4.99%
September 30, 2024
Summary
- As of February 20, 2025, CUE TTM net profit is -$44.61 million, with the most recent change of +$2.35 million (+4.99%) on September 30, 2024.
- Over the past year, CUE TTM net income has increased by +$2.35 million (+4.99%).
- CUE TTM net income is now -2104.04% below its all-time high of -$2.02 million, reached on September 30, 2016.
Performance
CUE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CUE Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +4.3% | +14.9% | +5.0% |
3 y3 years | -13.3% | +40.6% | +15.8% |
5 y5 years | -30.1% | +40.6% | +15.8% |
CUE Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -14.9% | +4.3% | -3.3% | +40.6% | -1.0% | +15.8% |
5 y | 5-year | -38.2% | +4.3% | -3.3% | +40.6% | -21.6% | +15.8% |
alltime | all time | -2530.4% | +4.3% | -327.8% | +40.6% | -2104.0% | +15.8% |
Cue Biopharma Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$8.66 M(-14.9%) | -$44.61 M(-5.0%) |
Jun 2024 | - | -$10.17 M(-17.6%) | -$46.96 M(-6.0%) |
Mar 2024 | - | -$12.35 M(-8.1%) | -$49.97 M(-1.5%) |
Dec 2023 | -$50.73 M(-4.3%) | -$13.43 M(+22.1%) | -$50.73 M(-2.2%) |
Sep 2023 | - | -$11.01 M(-16.5%) | -$51.89 M(+0.1%) |
Jun 2023 | - | -$13.19 M(+0.6%) | -$51.84 M(-0.0%) |
Mar 2023 | - | -$13.11 M(-10.2%) | -$51.86 M(-2.2%) |
Dec 2022 | -$53.01 M(+20.0%) | -$14.59 M(+33.2%) | -$53.01 M(+13.3%) |
Sep 2022 | - | -$10.96 M(-17.1%) | -$46.80 M(-4.2%) |
Jun 2022 | - | -$13.21 M(-7.3%) | -$48.84 M(+6.4%) |
Mar 2022 | - | -$14.26 M(+70.0%) | -$45.91 M(+4.0%) |
Dec 2021 | -$44.16 M(-1.4%) | -$8.38 M(-35.5%) | -$44.16 M(-5.8%) |
Sep 2021 | - | -$12.99 M(+26.4%) | -$46.88 M(+6.7%) |
Jun 2021 | - | -$10.28 M(-17.8%) | -$43.92 M(-1.2%) |
Mar 2021 | - | -$12.51 M(+12.6%) | -$44.47 M(-0.7%) |
Dec 2020 | -$44.78 M | -$11.10 M(+10.7%) | -$44.78 M(+5.1%) |
Sep 2020 | - | -$10.03 M(-7.4%) | -$42.60 M(+7.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2020 | - | -$10.83 M(-15.5%) | -$39.56 M(+3.4%) |
Mar 2020 | - | -$12.82 M(+43.7%) | -$38.25 M(+4.2%) |
Dec 2019 | -$36.70 M(-5.9%) | -$8.92 M(+27.6%) | -$36.70 M(-6.9%) |
Sep 2019 | - | -$6.99 M(-26.6%) | -$39.40 M(-12.4%) |
Jun 2019 | - | -$9.52 M(-15.5%) | -$44.97 M(+5.2%) |
Mar 2019 | - | -$11.27 M(-3.0%) | -$42.75 M(+9.6%) |
Dec 2018 | -$38.98 M(+67.8%) | -$11.62 M(-7.5%) | -$39.00 M(+3.1%) |
Sep 2018 | - | -$12.56 M(+72.0%) | -$37.82 M(+24.8%) |
Jun 2018 | - | -$7.30 M(-3.0%) | -$30.29 M(+10.5%) |
Mar 2018 | - | -$7.52 M(-27.9%) | -$27.41 M(+18.0%) |
Dec 2017 | -$23.23 M(+203.4%) | -$10.44 M(+107.4%) | -$23.23 M(+48.6%) |
Sep 2017 | - | -$5.03 M(+14.0%) | -$15.64 M(+23.8%) |
Jun 2017 | - | -$4.41 M(+31.7%) | -$12.63 M(+53.7%) |
Mar 2017 | - | -$3.35 M(+17.9%) | -$8.22 M(+68.8%) |
Dec 2016 | -$7.66 M(+297.1%) | -$2.84 M(+40.4%) | -$4.87 M(+140.4%) |
Sep 2016 | - | -$2.02 M | -$2.02 M |
Dec 2015 | -$1.93 M | - | - |
FAQ
- What is Cue Biopharma annual net profit?
- What is the all time high annual net income for Cue Biopharma?
- What is Cue Biopharma annual net income year-on-year change?
- What is Cue Biopharma quarterly net profit?
- What is the all time high quarterly net income for Cue Biopharma?
- What is Cue Biopharma quarterly net income year-on-year change?
- What is Cue Biopharma TTM net profit?
- What is the all time high TTM net income for Cue Biopharma?
- What is Cue Biopharma TTM net income year-on-year change?
What is Cue Biopharma annual net profit?
The current annual net income of CUE is -$50.73 M
What is the all time high annual net income for Cue Biopharma?
Cue Biopharma all-time high annual net profit is -$1.93 M
What is Cue Biopharma annual net income year-on-year change?
Over the past year, CUE annual net profit has changed by +$2.28 M (+4.30%)
What is Cue Biopharma quarterly net profit?
The current quarterly net income of CUE is -$8.66 M
What is the all time high quarterly net income for Cue Biopharma?
Cue Biopharma all-time high quarterly net profit is -$2.02 M
What is Cue Biopharma quarterly net income year-on-year change?
Over the past year, CUE quarterly net profit has changed by +$1.51 M (+14.86%)
What is Cue Biopharma TTM net profit?
The current TTM net income of CUE is -$44.61 M
What is the all time high TTM net income for Cue Biopharma?
Cue Biopharma all-time high TTM net profit is -$2.02 M
What is Cue Biopharma TTM net income year-on-year change?
Over the past year, CUE TTM net profit has changed by +$2.35 M (+4.99%)